120 related articles for article (PubMed ID: 36763165)
1. Self-assembly and self-delivery of the pure nanodrug dihydroartemisinin for tumor therapy and mechanism analysis.
Li Y; Zhang W; Shi N; Li W; Bi J; Feng X; Shi N; Zhu W; Xie Z
Biomater Sci; 2023 Mar; 11(7):2478-2485. PubMed ID: 36763165
[TBL] [Abstract][Full Text] [Related]
2. MOF nanoparticles with encapsulated dihydroartemisinin as a controlled drug delivery system for enhanced cancer therapy and mechanism analysis.
Li Y; Song Y; Zhang W; Xu J; Hou J; Feng X; Zhu W
J Mater Chem B; 2020 Aug; 8(33):7382-7389. PubMed ID: 32648887
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular hybrids of carbon dots and dihydroartemisinin for enhanced anticancer activity and mechanism analysis.
Li Y; Shi N; Zhang W; Zhang H; Song Y; Zhu W; Feng X
J Mater Chem B; 2020 Nov; 8(42):9777-9784. PubMed ID: 33026041
[TBL] [Abstract][Full Text] [Related]
4. Novel carrier-free nanoparticles composed of 7-ethyl-10-hydroxycamptothecin and chlorin e6: Self-assembly mechanism investigation and in vitro/in vivo evaluation.
Zhao Y; Zhao Y; Ma Q; Zhang H; Liu Y; Hong J; Ding Z; Liu M; Han J
Colloids Surf B Biointerfaces; 2020 Apr; 188():110722. PubMed ID: 31887649
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate.
Liu K; Dai L; Li C; Liu J; Wang L; Lei J
Sci Rep; 2016 Jul; 6():29461. PubMed ID: 27377918
[TBL] [Abstract][Full Text] [Related]
6. A redox-responsive dihydroartemisinin dimeric nanoprodrug for enhanced antitumor activity.
Li Y; Pei Q; Cui B; Zhang H; Han L; Li W; Zhu W; Feng X; Xie Z
J Nanobiotechnology; 2021 Dec; 19(1):441. PubMed ID: 34930288
[TBL] [Abstract][Full Text] [Related]
7. PEGylated-Paclitaxel and Dihydroartemisinin Nanoparticles for Simultaneously Delivering Paclitaxel and Dihydroartemisinin to Colorectal Cancer.
Phung CD; Le TG; Nguyen VH; Vu TT; Nguyen HQ; Kim JO; Yong CS; Nguyen CN
Pharm Res; 2020 Jun; 37(7):129. PubMed ID: 32548664
[TBL] [Abstract][Full Text] [Related]
8. Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.
Zhao R; Zheng G; Fan L; Shen Z; Jiang K; Guo Y; Shao JW
Acta Biomater; 2018 Apr; 70():197-210. PubMed ID: 29408311
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled dihydroartemisinin nanoparticles as a platform for cervical cancer chemotherapy.
Lu Y; Wen Q; Luo J; Xiong K; Wu Z; Wang B; Chen Y; Yang B; Fu S
Drug Deliv; 2020 Dec; 27(1):876-887. PubMed ID: 32516033
[TBL] [Abstract][Full Text] [Related]
10. pH-Sensitive Nanoparticles Codelivering Docetaxel and Dihydroartemisinin Effectively Treat Breast Cancer by Enhancing Reactive Oxidative Species-Mediated Mitochondrial Apoptosis.
Tao J; Diao L; Chen F; Shen A; Wang S; Jin H; Cai D; Hu Y
Mol Pharm; 2021 Jan; 18(1):74-86. PubMed ID: 33084332
[TBL] [Abstract][Full Text] [Related]
11. Construction of reduction-sensitive heterodimer prodrugs of doxorubicin and dihydroartemisinin self-assembled nanoparticles with antitumor activity.
Ren G; Duan D; Wang G; Wang R; Li Y; Zuo H; Zhang Q; Zhang G; Zhao Y; Wang R; Zhang S
Colloids Surf B Biointerfaces; 2022 Sep; 217():112614. PubMed ID: 35700564
[TBL] [Abstract][Full Text] [Related]
12. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
[TBL] [Abstract][Full Text] [Related]
13. Carrier-Free, Chemophotodynamic Dual Nanodrugs via Self-Assembly for Synergistic Antitumor Therapy.
Zhang R; Xing R; Jiao T; Ma K; Chen C; Ma G; Yan X
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13262-9. PubMed ID: 27176934
[TBL] [Abstract][Full Text] [Related]
14. Encapsulation of low lipophilic and slightly water-soluble dihydroartemisinin in PLGA nanoparticles with phospholipid to enhance encapsulation efficiency and in vitro bioactivity.
Wang L; Wang Y; Wang X; Sun L; Zhou Z; Lu J; Zheng Y
J Microencapsul; 2016 Feb; 33(1):43-52. PubMed ID: 26626402
[TBL] [Abstract][Full Text] [Related]
15. Self-Assembled Nanoparticles Platform Based on Pectin-Dihydroartemisinin Conjugates for Codelivery of Anticancer Drugs.
Liu Y; Zheng D; Ma Y; Dai J; Li C; Xiao S; Liu K; Liu J; Wang L; Lei J; He J
ACS Biomater Sci Eng; 2018 May; 4(5):1641-1650. PubMed ID: 33445320
[TBL] [Abstract][Full Text] [Related]
16. Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy.
Fan L; Zhang B; Xu A; Shen Z; Guo Y; Zhao R; Yao H; Shao JW
Mol Pharm; 2018 Jun; 15(6):2466-2478. PubMed ID: 29727577
[TBL] [Abstract][Full Text] [Related]
17. A Small Molecule Nanodrug by Self-Assembly of Dual Anticancer Drugs and Photosensitizer for Synergistic near-Infrared Cancer Theranostics.
Guo Y; Jiang K; Shen Z; Zheng G; Fan L; Zhao R; Shao J
ACS Appl Mater Interfaces; 2017 Dec; 9(50):43508-43519. PubMed ID: 29171263
[TBL] [Abstract][Full Text] [Related]
18. α-Fe
Xu Y; Xiao L; Chen J; Wu Q; Yu W; Zeng W; Shi Y; Lu Y; Liu Y
Acta Biomater; 2022 Sep; 150():367-379. PubMed ID: 35917907
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin: A Potential Natural Anticancer Drug.
Dai X; Zhang X; Chen W; Chen Y; Zhang Q; Mo S; Lu J
Int J Biol Sci; 2021; 17(2):603-622. PubMed ID: 33613116
[TBL] [Abstract][Full Text] [Related]
20. Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles.
Omwoyo WN; Melariri P; Gathirwa JW; Oloo F; Mahanga GM; Kalombo L; Ogutu B; Swai H
Nanomedicine; 2016 Apr; 12(3):801-809. PubMed ID: 26724538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
